Livongo Health, the startup company headed by former Allscripts CEO Glen Tullman, has received $20 million in funding.
The company, which has created a chronic diabetes management program, plans to use the funding to accelerate adoption. Already, Livongo has signed agreements with Office Depot, Iron Mountain, and other large Fortune 100 companies who double as self-insured employers. It also has paired with Partners Health System and a few other notable healthcare provider organizations.
The program, Livongo for Diabetes, allows patients to manage their diabetes on a mobile platform. It provides patients with a device that tracks their blood-glucose levels and takes that informations and integrates it with historical data, clinical rules and predictive modeling. It then aims to convert it into useable information for the patient.
The $20 million investment was led by Kleiner Perkins Caufield & Byers (KPCB), DFJ and previous investor General Catalyst. A few people, including Beth Seidenberg, M.D., general partner at KPCB, join the company's Board of Directors as part of the deal.
"We are very pleased to receive the support and insight of some of Silicon Valley’s premier healthcare investors,” Tullman, Chief Executive Officer at Livongo Health, said in a statement. “With thousands of people now using Livongo for Diabetes, it’s clear that the best way for people to manage chronic diseases like diabetes is to empower them with real-time, personalized information about their condition. This information improves care, reduces costs, and enables people to focus on their lives and not their diseases.”
